Boston is eyeing a return to a World Series hero, Nathan Eovaldi. A controllable, high-leverage starter with a championship pedigree could anchor the Sox rotation and spark a pennant run.
As the All-Star break sits further in the rearview, the Red Sox have made it clear: impact starting pitching is their priority, favoring club-controlled arms over short-term rentals. With a middling 4.03 ERA and just 32 wins credited to starters, Craig Breslow is eyeing established options. That intersection of performance and contract length brings Nathan Eovaldi to the forefront.
Boston acquired Eovaldi midseason in 2018, and he instantly became a rotation linchpin—capable of going deep and delivering in big moments. His legendary 12th-inning relief stint in Game 4 of the 2018 World Series, throwing six vital innings, is the stuff of Red Sox lore . Now 35, he’s not just a sentimental pick; he’s delivering one of the best seasons of his career.
In 2025 with Texas, Eovaldi has posted a 1.58 ERA across 91 innings (though just shy of qualifying for the leaderboard), a 0.85 WHIP, and a dominant strikeout-to-walk ratio (94 K, 14 BB). This isn’t a fade—it’s a resurgence, marked by command, consistency, and post‑season experience.
Nathan Eovaldi lowers his ERA to 1.58 over 91 IP this season! pic.twitter.com/ccB0oAxbP9
— MLB (@MLB) July 13, 2025
What Eovaldi Brings to the Table
-
Championship Proven – Two-time World Series winner (2018, 2023) and postseason horse; he led the 2023 Rangers with five playoff wins.
-
Contract Control – Under contract through 2027 via a three-year, $75 million deal, Eovaldi offers more than just short-term relief.
-
Top Rotation Filler – Adds innings, stability, and elite peripherals to a staff hit by inconsistency and overuse.
-
Leadership & Poise – A clubhouse veteran who commands respect and brings postseason pedigree.
Per @JeffPassan, the Rangers are gifting Nathan Eovaldi the $100,000 All-Star bonus despite not being named to the team
Evo has been phenomenal for Texas in ‘25 posting a MLB best 1.58 ERA and 0.85 WHIP, trailing only the reigning Cy Young Tarik Skubal pic.twitter.com/avQ8ZHdoWR
— Rangers Nation ⚾️ (@rangers__nation) July 16, 2025
Fit, Role & Tempo
Boston’s current rotation is built on youth and upside—Brayan Bello, Garrett Whitlock, Kutter Crawford—but lacks a proven veteran to pace the staff. Eovaldi fills that role naturally:
-
Reliability: Averaging 30+ starts in multiple seasons, even with health misses.
-
Mechanical Adjustability: Hallmarked by command and soft-contact inducing arsenal.
-
Accrued Leadership: His postseason cred lends mentorship to a young rotation.
Manager Alex Cora would benefit from Eovaldi’s comfort in big games. Whether anchoring Thursday rotation turns or spot-starting in October, his flexibility reinforces Boston’s pitchability down the stretch.
What It Might Cost Boston
Texas sits at 48–49 and may entertain deals. While not currently committed to selling, their payroll dynamics and lack of contention suggest they wouldn’t demand top-tier prospects. Boston’s deep farm, loaded with mid- and lower-level arms, can craft a viable offer without hitting the core of the prospect pool. A package built around upper-minors pitching depth (velocity and future payoff) could be sufficient.
I feel like not enough people are talking about how Nathan Eovaldi has a 1.58 ERA and 0.85 WHIP in 16 starts this season…pic.twitter.com/bSJzWnDSHX
— Eric Cross (@EricCrossMLB) July 14, 2025
Risks & Considerations
-
Injury History: Eovaldi missed time in 2022 due to back and shoulder inflammation. But his strong 2025 return suggests sound mechanics.
-
Contract Salary: $25M per year is significant, though manageable given Boston’s financial flexibility.
-
Trade Competition: Other playoff-caliber teams could bid, raising the cost or forcing Boston to consider alternatives, such as Joe Ryan.
This is more than a nostalgia move. It’s a high-caliber acquisition aimed at fortifying the rotation for a second consecutive postseason push. Eovaldi offers high-stakes innings, postseason familiarity, and immediate stability.
If Boston wants to claim the AL East or build a team for October, this feels like a move Breslow could be exploring. The Sox front office—led by Cora’s comfort and Eovaldi’s club familiarity—makes this reunion plausible, appealing, and maybe, just maybe, championship-caliber.
Trade Target Recap
-
Nathan Eovaldi (RHP, Texas Rangers) – 1.58 ERA, 0.85 WHIP, 94 K/14 BB over 91 IP; controlled through 2027 on $75M deal.
-
Role: Top‑3 starter in Boston’s rotation; innings eater; veteran playoff veteran
-
Trade Package Potential: Upper-minor pitchers plus secondary prospects
-
Upside: Immediate boost, postseason insurance, rotation stability
-
Drawbacks: Age, moderate health risk, significant salary
